Avutometinib and Defactinib
About
Membership operator: AND
Therapies: 2
Therapies
Avutometinib (tx:ncit:C80060)
Defactinib (tx:ncit:C79809)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) | KRAS p.G12C | Low-Grade Serous Ovarian Cancer | Avutometinib, Defactinib | |
| FDA (2) | KRAS p.G12V | Low-Grade Serous Ovarian Cancer | Avutometinib, Defactinib |